Literature DB >> 8107220

Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate.

M Vanden Haesevelde1, J L Decourt, R J De Leys, B Vanderborght, G van der Groen, H van Heuverswijn, E Saman.   

Abstract

Analysis of the complete sequence of a human immunodeficiency virus (HIV) isolate (Ant70) obtained from a Cameroonian patient indicates that this virus is the most divergent strain within the HIV-1 family hitherto described. Comparison of the Pol protein, usually highly conserved within the HIV-1 family, shows only about 73% similarity with the HIVmm isolate, whereas for the more variable proteins such as envelope, similarities of 50% or lower are found. The principal neutralizing determinant (V3 loop) and the immunodominant region within gp41 also contain some unusual substitutions, which may have implications for protein function as well as for serological assays based on these regions. Phylogenetic analyses show that this isolate occupies a unique position relative to the human HIV-1 isolates and the recently described SIVcpz virus, indicating that this Cameroonian isolate may provide us with new insights into the origins of the HIV-1 family.

Entities:  

Keywords:  Africa; Biology; Developing Countries; Diseases; Examinations And Diagnoses; Genetics; Hiv Infections; Laboratory Examinations And Diagnoses; Laboratory Procedures; Viral Diseases

Mesh:

Year:  1994        PMID: 8107220      PMCID: PMC236616     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding.

Authors:  U Olshevsky; E Helseth; C Furman; J Li; W Haseltine; J Sodroski
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

2.  Activity of synthetic tat peptides in human immunodeficiency virus type 1 long terminal repeat-promoted transcription in a cell-free system.

Authors:  J Jeyapaul; M R Reddy; S A Khan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology.

Authors:  F Clavel; J M Orenstein
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Origin and spread of AIDS.

Authors:  A Karpas
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

5.  Prediction of beta-turns.

Authors:  P Y Chou; G D Fasman
Journal:  Biophys J       Date:  1979-06       Impact factor: 4.033

6.  Antigenic evidence of the presence of the aberrant HIV-1ant70 virus in Cameroon and Gabon.

Authors:  J N Nkengasong; M Peeters; M vanden Haesevelde; S S Musi; B Willems; P M Ndumbe; E Delaporte; J L Perret; P Piot; G van den Groen
Journal:  AIDS       Date:  1993-11       Impact factor: 4.177

7.  Mutagenesis of EIAV TAT reveals structural features essential for transcriptional activation and TAR element recognition.

Authors:  D Derse; S H Newbold
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

8.  Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein.

Authors:  F Maldarelli; M Y Chen; R L Willey; K Strebel
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

9.  A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.

Authors:  L G Gürtler; P H Hauser; J Eberle; A von Brunn; S Knapp; L Zekeng; J M Tsague; L Kaptue
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  54 in total

1.  Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses.

Authors:  D Descamps; G Collin; F Letourneur; C Apetrei; F Damond; I Loussert-Ajaka; F Simon; S Saragosti; F Brun-Vézinet
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein.

Authors:  Feng Gao; Eric A Weaver; Zhongjing Lu; Yingying Li; Hua-Xin Liao; Benjiang Ma; S Munir Alam; Richard M Scearce; Laura L Sutherland; Jae-Sung Yu; Julie M Decker; George M Shaw; David C Montefiori; Bette T Korber; Beatrice H Hahn; Barton F Haynes
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Multicenter evaluation of new double-antigen sandwich enzyme immunoassay for measurement of anti-human immunodeficiency virus type 1 and type 2 antibodies.

Authors:  P Burgisser; F Simon; M Wernli; T Wust; M F Beya; P C Frei
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

4.  Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies.

Authors:  J P Moore; F E McCutchan; S W Poon; J Mascola; J Liu; Y Cao; D D Ho
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Functional analysis of the core human immunodeficiency virus type 1 packaging signal in a permissive cell line.

Authors:  G P Harrison; G Miele; E Hunter; A M Lever
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

6.  Searching for an effective, safe and universal anti-HIV vaccine: Finding the answer in just one short peptide.

Authors:  Guglielmo Lucchese; Angela Stufano; Darja Kanduc
Journal:  Self Nonself       Date:  2011-01-01

7.  Fast analysis of genomic homologies: primate immunodeficiency virus.

Authors:  M L Moncany; P R Courtois
Journal:  J Mol Evol       Date:  1996-08       Impact factor: 2.395

8.  Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.

Authors:  A Trkola; A B Pomales; H Yuan; B Korber; P J Maddon; G P Allaway; H Katinger; C F Barbas; D R Burton; D D Ho
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: evidence for cross-species transmission in the wild.

Authors:  M J Jin; J Rogers; J E Phillips-Conroy; J S Allan; R C Desrosiers; G M Shaw; P M Sharp; B H Hahn
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.

Authors:  L G Gürtler; P H Hauser; J Eberle; A von Brunn; S Knapp; L Zekeng; J M Tsague; L Kaptue
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.